Marsh & Mclennan Companies, Inc.
Congress has disclosed 0 buys and 6 sells of MRSH (Marsh & Mclennan Companies, Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Insurance. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
how it's calculated
how it's calculated
how it's calculated
Legislation Related Legislation
Recent bills in this stock's sector (Insurance). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.
| Bill | Title | Policy area | Latest action |
|---|---|---|---|
| HR 10820 | Epstein Wall Street Records Act of 2026 | Finance and Financial Sector | 2026-10-15 |
| HR 10821 | To amend the Federal Deposit Insurance Act to make changes to the Standard Maximum Deposit Insurance Amount, and for other purposes. | Finance and Financial Sector | 2026-10-15 |
| S 4395 | Terrorism Risk Insurance Program Reauthorization Act of 2026 | Finance and Financial Sector | 2026-10-05 |
| S 1564 | Floodplain Enhancement and Recovery Act | Finance and Financial Sector | 2026-10-05 |
| S 5644 | A bill to amend title 31, United States Code, to exempt transactions with respect to cash reward payments by crime stopper organizations from certain currency transaction reports. | Finance and Financial Sector | 2026-09-30 |
7 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Kevin Hern | House | SELL ◆ insider convergence · moderate | Joint · Hern Family Revocable Trust | 2026-09-23 | 9 days | +0.4% | $50K–$100K 0.9% of NW |
82.3 | ↗ filing |
| Kevin Hern | House | SELL ◆ insider convergence · moderate | Joint · Hern Family Revocable Trust | 2026-09-17 | 15 days | -2.0% | $50K–$100K 0.9% of NW |
69.7 | ↗ filing |
| Kevin Hern | House | SELL ◆ insider convergence · moderate | Joint · Hern Family Revocable Trust | 2026-09-14 | 1 days | -0.4% | $1K–$15K 0.1% of NW |
54.7 | ↗ filing |
| Kevin Hern | House | SELL ◆ insider convergence · moderate | Joint · Hern Family Revocable Trust | 2026-09-09 | 6 days | +1.7% | $100K–$250K 2.1% of NW |
93.7 | ↗ filing |
| Kevin Hern | House | SELL ◆ insider convergence · moderate | Joint · Hern Family Revocable Trust | 2026-09-02 | 13 days | -4.3% | $1K–$15K 0.1% of NW |
62.9 | ↗ filing |
| Kevin Hern | House | SELL ◆ insider convergence · moderate | Joint · Hern Family Foundation | 2026-08-24 | 3 days | -2.4% | $1K–$15K 0.1% of NW |
89.6 | ↗ filing |
| Alan Armstrong | Senate | OTHER | Self | 2026-03-27 | 116 days | +7.9% | $1K–$15K | 82.9 | ↗ eFD |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in MRSH — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
Of the congressional trades in MRSH, 6 coincided with corporate insiders moving the same way within 60 days, and 0 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-10-23 | Mills Stacy | Other | SELL 10b5-1 | $243K | ↗ EDGAR |
| 2026-10-23 | Klisura Dean Michael | C-suite | SELL 10b5-1 | $839K | ↗ EDGAR |
| 2026-09-02 | Doyle John Q | C-suite | SELL 10b5-1 | $3.1M | ↗ EDGAR |
| 2026-09-02 | Brennan Katherine | Other | SELL | $225K | ↗ EDGAR |
| 2026-08-06 | Jones John Jude | C-suite | SELL | $1.2M | ↗ EDGAR |
| 2026-07-29 | Beswick Paul | C-suite | SELL 10b5-1 | $141K | ↗ EDGAR |
| 2026-07-28 | South Martin | C-suite | SELL | $1.3M | ↗ EDGAR |
| 2026-07-23 | Yates Lloyd M | Director | SELL | $2.1M | ↗ EDGAR |
| 2026-06-02 | Doyle John Q | C-suite | SELL 10b5-1 | $2.7M | ↗ EDGAR |
| 2026-03-11 | Jones John Jude | C-suite | SELL | $410K | ↗ EDGAR |
| 2026-03-04 | Doyle John Q | C-suite | SELL 10b5-1 | $3.1M | ↗ EDGAR |
| 2026-03-03 | Studer Nicholas Mark | C-suite | SELL | $706K | ↗ EDGAR |
| 2025-12-01 | Doyle John Q | C-suite | SELL 10b5-1 | $3.8M | ↗ EDGAR |
| 2025-09-02 | Doyle John Q | C-suite | SELL 10b5-1 | $4.3M | ↗ EDGAR |
| 2025-07-30 | Anderson Anthony | Director | BUY | $101K | ↗ EDGAR |
| 2025-07-29 | Anderson Anthony | Director | BUY | $101K | ↗ EDGAR |
| 2025-06-02 | Doyle John Q | C-suite | SELL 10b5-1 | $4.9M | ↗ EDGAR |
| 2025-04-03 | Beswick Paul | C-suite | SELL 10b5-1 | $550K | ↗ EDGAR |
| 2025-03-31 | Klisura Dean Michael | C-suite | SELL 10b5-1 | $2.3M | ↗ EDGAR |
| 2025-03-12 | Studer Nicholas Mark | C-suite | SELL | $11.4M | ↗ EDGAR |
| 2025-03-10 | Mills Stacy | Other | SELL 10b5-1 | $309K | ↗ EDGAR |
| 2025-03-10 | MCGIVNEY MARK C | C-suite | SELL 10b5-1 | $2.5M | ↗ EDGAR |
| 2025-03-10 | Klisura Dean Michael | C-suite | SELL 10b5-1 | $1.7M | ↗ EDGAR |
| 2025-03-06 | Jones John Jude | C-suite | SELL | $241K | ↗ EDGAR |
| 2025-03-06 | Jones John Jude | C-suite | SELL | $1.1M | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| ◆ insider | 2026-10-23 | Mills Stacy Other 10b5-1 | SELL | $243K |
| ◆ insider | 2026-10-23 | Klisura Dean Michael C-suite 10b5-1 | SELL | $839K |
| Congress | 2026-09-23 | Kevin Hern | SELL | $50K–$100K |
| Congress | 2026-09-17 | Kevin Hern | SELL | $50K–$100K |
| Congress | 2026-09-14 | Kevin Hern | SELL | $1K–$15K |
| Congress | 2026-09-09 | Kevin Hern | SELL | $100K–$250K |
| Congress | 2026-09-02 | Kevin Hern | SELL | $1K–$15K |
| ◆ insider | 2026-09-02 | Doyle John Q C-suite 10b5-1 | SELL | $3.1M |
| ◆ insider | 2026-09-02 | Brennan Katherine Other | SELL | $225K |
| Congress | 2026-08-24 | Kevin Hern | SELL | $1K–$15K |
| ◆ insider | 2026-08-06 | Jones John Jude C-suite | SELL | $1.2M |
| ◆ insider | 2026-07-29 | Beswick Paul C-suite 10b5-1 | SELL | $141K |
| ◆ insider | 2026-07-28 | South Martin C-suite | SELL | $1.3M |
| ◆ insider | 2026-07-23 | Yates Lloyd M Director | SELL | $2.1M |
| ◆ insider | 2026-06-02 | Doyle John Q C-suite 10b5-1 | SELL | $2.7M |
| Congress | 2026-03-27 | Alan Armstrong | OTHER | $1K–$15K |
| ◆ insider | 2026-03-11 | Jones John Jude C-suite | SELL | $410K |
| ◆ insider | 2026-03-04 | Doyle John Q C-suite 10b5-1 | SELL | $3.1M |
| ◆ insider | 2026-03-03 | Studer Nicholas Mark C-suite | SELL | $706K |
| ◆ insider | 2025-12-01 | Doyle John Q C-suite 10b5-1 | SELL | $3.8M |
| ◆ insider | 2025-09-02 | Doyle John Q C-suite 10b5-1 | SELL | $4.3M |
| ◆ insider | 2025-07-30 | Anderson Anthony Director | BUY | $101K |
| ◆ insider | 2025-07-29 | Anderson Anthony Director | BUY | $101K |
| ◆ insider | 2025-06-02 | Doyle John Q C-suite 10b5-1 | SELL | $4.9M |
FAQ Common questions
How much has Congress traded MRSH?
0 disclosed buys and 6 sells of MRSH (Marsh & Mclennan Companies, Inc.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade MRSH?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.